Repeated isolation of Pseudomonas aeruginosa isolates resistant to both polymyxins and carbapenems from 1 patient

Diagnostic Microbiology and Infectious Disease

Volumn 72, Issue 3, 2012, Pages 267-271

  Lee, Ji Young ^a   Lim, Min Hee ^a   Heo, Sang Taek ^b   Ko, Kwan Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Jeju National University College of Medicine   (South Korea)

Author keywords

Colistin; IMP 6; Pseudomonas aeruginosa; ST235

Indexed keywords

BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE; COLISTIN; PHOP PROTEIN; PMRB PROTEIN; POLYMYXIN DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLAGIM GENE; BLAIMP GENE; BLAOXA 50 GENE; BLASIM GENE; BLASPM GENE; BLAVIM GENE; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHOP GENE; PMRB GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; REPEAT PROCEDURE; SEQUENCE ANALYSIS;

AGED; AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; MUTATION; POLYMYXINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TRANSCRIPTION FACTORS;

EID: 84856619953     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2011.11.014     Document Type: Article

References (26)

1. Abraham N., Kwon D.H. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 2009, 298:249-254.
2. Adams M.D., Nickel G.C., Bajaksouzian S., Lavender H., Murthy A.R., Jacobs M.R., Bonomo R.A. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob. Agents Chemother. 2009, 53:3628-3634.
3. Barrow K., Kwon D.H. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2009, 53:5150-5154.
4. Bergen P.J., Li J., Nation R.L., Turnidge J.D., Coulthar K., Milne R.W. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J. Antimicrob. Chemother. 2008, 61:636-642.
5. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 21st information supplement (M100-S21) 2011, CLSI, Wayne, PA.
6. Curran B., Jonas D., Grundmann H., Pitt H., Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. J. Clin. Microbiol. 2004, 42:5644-5649.
7. Denton M., Kerr K., Mooney L., Keer V., Rajgopa A., Brownlee K., Arundel A., Conway S. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center. Pediatr. Pulmonol. 2002, 34:257-261.
8. Deplano A., Denis O., Poirel L., Hocquet D., Nonhoff C., Byl B., Nordmann P., Vincent J.L., Struelens M.J. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J. Clin. Microbiol. 2005, 43:1198-1204.
9. Ellington M.J., Kistler J., Livermore D.M., Woodford N. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J. Antimicrob. Chemother. 2007, 59:321-322.
10. Falagas M.E., Koletsi P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 2006, 55:1619-1629.
11. Falagas M.E., Bliziotis I.A., Kasiakou S.K., Kasiakou S.K., Samonis G., Athanassopoulu P., Michalopoulos A. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect. Dis. 2005, 5:24.
12. Falagas M.E., Rafilidis P.I., Matthaiou D.K., Virtzili S., Nikita D., Michalopoulos A., et al. Pandrug-resistant Klebsiella pneumonia, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int. J. Antimicrob. Agents 2008, 32:450-454.
13. Fernández L., Gooderham W.J., Bains M., McPhee J.B., Wiegand I., Hancock R.E.W. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 2010, 54:3372-3382.
14. Hawley J.S., Murray C.K., Jorgensen J.H. Colistin heteroresistance in Acinetobacter and its association with previous colistin therapy. Antimicrob. Agents Chemother. 2008, 52:351-352.
15. Lee J.Y., Song J.H., Ko K.S. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea. Microb. Drug Resist. 2011, 17:299-304.
16. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., Liolios L. Hetero-resistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2006, 50:2946-2950.
17. Li R., Nation R.L., Owen R.J., Wong S., Spelman D., Franklin C. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin. Infect. Dis. 2007, 45:594-598.
18. Mendes R.E., Fritsche T.R., Sader H.S., Jones R.N. Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates. Clin. Infect. Dis. 2008, 46:1324-1326.
19. Mentzelopoulos S.D., Pratikaki M., Platsouka E., Kraniotaki H., Zervakis D., Koutsoukou A., Nanas S., Paniara O., Roussos C., Giamarellos-Bourboulis E., Routsi C., Zakynthinos S.G. Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandurg-resistant Pseudmonas aeruginosa. Intensive Care Med. 2007, 33:1524-1532.
20. Mitrophanov A.Y., Jewett M.W., Hadley T.J., Groisman E.A. Evolution and dynamics of regulatory architectures controlling polymyxin B resistance in enteric bacteria. PLoS Genet. 2008, 4:e1000233.
21. Moskowitz S.M., Ernst R.K., Miller S.I. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid. J. Bacteriol. 2004, 186:575-579.
22. Ryoo N.H., Lee K., Lim J.B., Lee Y.H., Bae I.K., Jeong S.H. Outbreak by meropenem-resistant Pseudomonas aeruginosa producing IMP-6 metallo-β-lactamase in a Korean hospital. Diagn. Microbiol. Infect. Dis. 2009, 63:115-117.
23. Schurek K.N., Sampaio J.L.M., Kiffer C.R.V., Sinto S., Mendes C.M.F., Hancock R.E.W. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2009, 53:4345-4351.
24. Tan C.H., Li J., Nation R.L. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob. Agents Chemother. 2007, 51:3413-3415.
25. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 2011, 35:736-755.
26. Yano H., Kuga A., Okamoto R., Kitasato H., Kobayashi T., Inoue M. Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob. Agents Chemother. 2001, 45:1343-1348.